GlassScriptPhysician profile
Marlene Adesca
NPI 1376895730
$2,193.62
in general payments reported to CMS, 2019-2025
17 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $399 · 2022: $696 · 2023: $451 · 2024: $456 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $732.34 | 2021-2025 | Dovato, Apretude |
| Janssen Biotech, INC. | $336.51 | 2021-2023 | Symtuza, Prezcobix |
| Janssen Products, LP | $220.53 | 2021-2022 | |
| Exact Sciences Corporation | $208.66 | 2023-2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $194.28 | 2021-2025 | |
| Lilly USA, LLC | $106.75 | 2022-2024 | Mounjaro, Jardiance, Zepbound |
| Hologic Sales and Service, LLC | $91.68 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Novo Nordisk INC | $59.18 | 2022-2023 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $51.30 | 2022-2024 | Pifeltro, Delstrigo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.01 | 2022-2023 | Jardiance |
| Abbott Laboratories | $39.72 | 2023-2024 | Proclaim, Freestyle Libre |
| Glaxosmithkline, LLC. | $21.75 | 2022 | |
| Dexcom, INC. | $19.63 | 2025 | Dexcom G6 Transmitter |
| Organon LLC | $18.67 | 2024 | |
| Phadia US INC. | $17.71 | 2023 | Immunocap |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $17.27 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.63 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlene Adesca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.